Related Experiment Videos
[Juvenile arthritides]
1Zentrum für Allgemeine Pädiatrie und Neonatologie und Kinderrheumazentrum, Asklepios Klinik Sankt Augustin, Deutschland. g.horneff@asklepios.com
Insights
Diagnosing and treating childhood arthritis, particularly juvenile idiopathic arthritis (JIA), requires careful consideration of various conditions. This guide outlines diagnostic approaches and evidence-based therapies for JIA, including medications and biologics.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Pharmacology
Context:
- Childhood arthritis presents complex diagnostic and therapeutic challenges.
- A precise approach is crucial, especially for young children.
- The differential diagnosis includes acute arthritides and chronic conditions like juvenile idiopathic arthritis (JIA).
Purpose:
- To provide a guide for diagnosing arthritis in children.
- To outline evidence-based therapeutic strategies for JIA.
Summary:
- This overview covers the diagnostic spectrum of pediatric arthritis.
- It details the evidence-based treatment of JIA, encompassing NSAIDs, corticosteroids, traditional DMARDs (sulfasalazine, methotrexate, leflunomide), TNF inhibitors (etanercept, adalimumab, infliximab), other biopharmaceuticals (anakinra, canakinumab, rilonacept), tocilizumab, and abatacept.
Impact:
- Aids clinicians in accurate diagnosis and management of pediatric arthritis.
- Facilitates informed therapeutic decisions for JIA based on current evidence.
- Contributes to improved outcomes for children with inflammatory joint diseases.
Abstract:
Arthritis in children represents a diagnostic and therapeutic challenge. The diagnostic spectrum is broad and a very precise indication for diagnostic and therapeutic procedures, especially in small children, is important. In addition to acute arthritides - viral arthritis, reactive arthritis, Lyme arthritis and septic arthritis - secondary chronic arthritis related to an underlying disease as well as juvenile idiopathic arthritis (JIA), the most common chronic inflammatory systemic disease in children, need to be considered. This overview is a guide to the diagnosis of arthritis in childhood and to evidence-based therapy of JIA in particular. This consists of a combination of nonsteroidal anti-inflammatory drugs, systemic and intraarticular corticosteroids, traditional DMARDs such as sulfasalazine, methotrexate and leflunomide, the TNF inhibitors etanercept, adalimumab and, with restrictions, infliximab, other biopharmaceuticals such as anakinra, canakinumab and rilonacept, and tocilizumab and finally, abatacept.
Related Concept Videos
Functional Classification of Joints
The functional classification of joints is determined by the amount of mobility between the adjacent bones. Joints are functionally classified as a synarthrosis or immobile joint, an amphiarthrosis or slightly moveable joint, or as a diarthrosis, a freely moveable joint. Fibrous and cartilaginous joints can be functionally classified as either synarthroses or amphiarthroses, whereas all synovial joints are classified as diarthroses.
Synarthrosis
An immobile...
Structural Joints: Synovial Joints
Development of the Limb Synovial Joints
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Structural Joints: Cartilaginous Joints
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary or...